Podcast
Questions and Answers
In multiple sclerosis, what is the primary mechanism by which activated macrophages contribute to demyelination?
In multiple sclerosis, what is the primary mechanism by which activated macrophages contribute to demyelination?
- Promoting the differentiation of B cells into antibody-secreting plasma cells targeting myelin.
- Inhibiting the migration of autoreactive T lymphocytes across the blood-brain barrier.
- Releasing injurious products that damage the myelin sheath. (correct)
- Directly stimulating oligodendrocytes to produce defective myelin.
How does the disruption of the axonal cytoskeleton contribute to the pathology of demyelinating diseases?
How does the disruption of the axonal cytoskeleton contribute to the pathology of demyelinating diseases?
- By increasing the speed of nerve impulse conduction.
- By promoting the regeneration of oligodendrocytes.
- By directly triggering the autoimmune response against myelin.
- By destabilizing the axon, leading to progressive axonal loss. (correct)
What is the primary role of CD4 Th1 cells in the pathogenesis of multiple sclerosis?
What is the primary role of CD4 Th1 cells in the pathogenesis of multiple sclerosis?
- Secreting cytokines that activate macrophages and enhance demyelination. (correct)
- Suppressing the activity of autoreactive B cells.
- Directly attacking and killing oligodendrocytes.
- Promoting the repair of damaged myelin sheaths.
Why are demyelinating diseases also referred to as myelinoclastic diseases?
Why are demyelinating diseases also referred to as myelinoclastic diseases?
Which of the following best describes the pattern of inheritance for susceptibility to multiple sclerosis?
Which of the following best describes the pattern of inheritance for susceptibility to multiple sclerosis?
How does myelin contribute to the metabolic efficiency of neurons?
How does myelin contribute to the metabolic efficiency of neurons?
What is the clinical significance of the relapsing and remitting pattern observed in many cases of multiple sclerosis?
What is the clinical significance of the relapsing and remitting pattern observed in many cases of multiple sclerosis?
In the context of multiple sclerosis, what is the role of the blood-brain barrier (BBB) in disease pathogenesis?
In the context of multiple sclerosis, what is the role of the blood-brain barrier (BBB) in disease pathogenesis?
In lesions characterized by thinner than normal myelin sheaths with lighter staining, what is the primary mechanism contributing to this change?
In lesions characterized by thinner than normal myelin sheaths with lighter staining, what is the primary mechanism contributing to this change?
Neuromyelitis optica (Devic’s disease) is characterized by which key clinical features?
Neuromyelitis optica (Devic’s disease) is characterized by which key clinical features?
Which of the following best describes the clinical course and pathological features of acute multiple sclerosis (Marburg type)?
Which of the following best describes the clinical course and pathological features of acute multiple sclerosis (Marburg type)?
Why is the treatment for multiple sclerosis considered 'unsatisfactory'?
Why is the treatment for multiple sclerosis considered 'unsatisfactory'?
What is the typical etiology and timeframe for the development of acute disseminated encephalomyelitis (ADEM)?
What is the typical etiology and timeframe for the development of acute disseminated encephalomyelitis (ADEM)?
What combination of clinical findings is most indicative of acute disseminated encephalomyelitis (ADEM) at its onset?
What combination of clinical findings is most indicative of acute disseminated encephalomyelitis (ADEM) at its onset?
What pathological feature is most characteristic of acute disseminated encephalomyelitis (ADEM) in the brain?
What pathological feature is most characteristic of acute disseminated encephalomyelitis (ADEM) in the brain?
In the context of demyelinating diseases, what distinguishes the pattern of demyelination in ADEM from that typically observed in multiple sclerosis?
In the context of demyelinating diseases, what distinguishes the pattern of demyelination in ADEM from that typically observed in multiple sclerosis?
Which characteristic distinguishes active MS plaques from inactive plaques?
Which characteristic distinguishes active MS plaques from inactive plaques?
What microscopic feature is characteristic of both active and inactive MS plaques?
What microscopic feature is characteristic of both active and inactive MS plaques?
What best differentiates shadow plaques from active or inactive plaques in multiple sclerosis?
What best differentiates shadow plaques from active or inactive plaques in multiple sclerosis?
What explains the pink-tan appearance of recent MS plaques upon gross examination?
What explains the pink-tan appearance of recent MS plaques upon gross examination?
Which region of the central nervous system is LEAST likely to show prominent plaque formation in multiple sclerosis?
Which region of the central nervous system is LEAST likely to show prominent plaque formation in multiple sclerosis?
What pathological process primarily accounts for the sharply defined borders observed at the microscopic level in MS lesions?
What pathological process primarily accounts for the sharply defined borders observed at the microscopic level in MS lesions?
What is the diagnostic significance of perivenular extension observed on MR images of MS plaques?
What is the diagnostic significance of perivenular extension observed on MR images of MS plaques?
An older MS plaque that appears grossly hyaline gray and rubbery likely indicates what?
An older MS plaque that appears grossly hyaline gray and rubbery likely indicates what?
Flashcards
Demyelination
Demyelination
The loss of the myelin sheath around nerves, leading to slower signal conduction.
Multiple Sclerosis
Multiple Sclerosis
An autoimmune demyelinating disorder with episodes of neurologic deficits.
Pathogenesis of Multiple Sclerosis
Pathogenesis of Multiple Sclerosis
Immune response targeting myelin, often initiated by autoreactive T lymphocytes.
Immune Trigger
Immune Trigger
Signup and view all the flashcards
CD4+ Th1 Cells
CD4+ Th1 Cells
Signup and view all the flashcards
Environmental Risk Factors
Environmental Risk Factors
Signup and view all the flashcards
Relapsing-Remitting Course
Relapsing-Remitting Course
Signup and view all the flashcards
Oligodendrocytes
Oligodendrocytes
Signup and view all the flashcards
Partial Myelin Loss
Partial Myelin Loss
Signup and view all the flashcards
Neuromyelitis Optica
Neuromyelitis Optica
Signup and view all the flashcards
Acute Multiple Sclerosis
Acute Multiple Sclerosis
Signup and view all the flashcards
ADEM
ADEM
Signup and view all the flashcards
ADEM Symptoms
ADEM Symptoms
Signup and view all the flashcards
Pathological Features of ADEM
Pathological Features of ADEM
Signup and view all the flashcards
Outcome of ADEM
Outcome of ADEM
Signup and view all the flashcards
Treatment Options for MS
Treatment Options for MS
Signup and view all the flashcards
Multiple Sclerosis Plaques
Multiple Sclerosis Plaques
Signup and view all the flashcards
Recent Plaques Appearance
Recent Plaques Appearance
Signup and view all the flashcards
Older Plaques Characteristics
Older Plaques Characteristics
Signup and view all the flashcards
Active Plaque
Active Plaque
Signup and view all the flashcards
Inactive Plaque
Inactive Plaque
Signup and view all the flashcards
Shadow Plaques
Shadow Plaques
Signup and view all the flashcards
Demyelination Process
Demyelination Process
Signup and view all the flashcards
Reactive Astrocytes
Reactive Astrocytes
Signup and view all the flashcards
Study Notes
Pathology of Demyelinating Diseases
- Demyelination is the loss of myelin, the protective sheath around nerve fibers
- Myelin is produced by oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system (PNS)
- Myelin increases the speed and efficiency of nerve conduction.
- Loss of myelin leads to decreased conduction velocity, axon instability and eventually, axonal loss.
- Demyelinating diseases involve the myelin sheath and can affect the entire nervous system.
Types of Demyelinating Diseases
- Multiple sclerosis (MS): An autoimmune demyelinating disorder characterized by distinct episodes of neurologic deficits (relapsing remitting).
- It is the most common demyelinating disorder.
- Females are more commonly affected.
- Age of onset is typically any age, rare in children and elderly.
- Clinical course is characterized by relapsing and remitting episodes of neurologic deficits, lasting weeks to months to years, with periods of partial recovery.
- Acute disseminated encephalomyelitis (ADEM): A monophasic demyelinating disease following a viral infection or immunization.
- Symptoms develop 1-2 weeks after infection.
- Clinical features include abrupt onset of headache, fever, confusion, stiff neck, progressing to severe cases with convulsions, cerebellar ataxia, cranial nerve palsies or coma.
- A significant percentage experience a fatal outcome.
- Complete recovery is possible.
- Acute necrotizing hemorrhagic encephalomyelitis: A fulminant and diffuse central nervous system demyelinating disease.
- It's a severe, hyperacute form of acute disseminated encephalomyelitis, primarily affecting young and children.
- Characterized by a rapid progression to coma and death within several days, and following an episode of an upper respiratory infection.
- Grossly, the brain demonstrates grayish discoloration.
- Microcopically, there is diffuse cerebral edema with petechial hemorrhages and large confluent areas of hemorrhagic necrosis.
- Fibrinoid necrosis of venules with perivascular edema, fibrin deposition and neutrophilic infiltrations, culminating in perivascular demyelination.
Morphology of Demyelinating Diseases
- MS:
- Plaques are typically irregular, sharply circumscribed areas of demyelination found primarily in periventricular white matter, optic nerves and tracts, brainstem and spinal cord.
- Plaques can also extend into grey matter.
- Recent plaques appear pink-tan and soft, while older plaques show hyaline gray appearance, being more rubbery or cystic.
- Variations in plaque size exist, from small foci to large confluent plaques.
- ADEM:
- Characterized by symmetrical involvement of the entire neuraxis.
- Intense perivenous inflammation (hallmark) consisting of lipid-laden macrophages and lymphocytes, surrounding areas of perivenous demyelination, and relatively sparing of axons.
- ANHE:
- Characterized by widespread destruction of myelin, presence of large confluent areas of hemorrhagic necrosis and diffuse cerebral edema with petechial hemorrhages.
- Fibrinoid necrosis of venules is evident, along with perivascular edema, fibrin deposition, and neutrophils infiltration.
Treatment of Demyelinating Diseases
- Treatment for demyelinating diseases, such as MS, are largely unsatisfactory.
- Immunosuppressive agents, including corticosteroids, can provide some benefit but aren't curative.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore the pathogenesis of multiple sclerosis, focusing on the roles of macrophages, axonal cytoskeleton disruption. The lecture questions cover the roles of CD4 Th1 cells, myelin's function, and the clinical significance of relapsing-remitting patterns. The impact of the blood-brain barrier on disease progression is also discussed.